Bactiguard

Executive Summary

Bactiguard is a Swedish MedTech company that has developed a proprietary, ultra-thin noble metal alloy coating technology for medical devices. The coating prevents microbial adhesion and biofilm formation, thereby reducing device-related infections—a critical need in healthcare. Founded in 2004 and headquartered in Stockholm, Bactiguard licenses its technology to medical device manufacturers and also markets a select portfolio of wound care products. The company's technology addresses the growing challenge of hospital-acquired infections, a significant burden on healthcare systems worldwide. Bactiguard's business model relies on licensing partnerships with established medical device companies, which provides a scalable path to market without the need for direct sales infrastructure. The company's coating has been integrated into urinary catheters, endotracheal tubes, and other devices, with clinical evidence supporting infection reduction. As regulatory scrutiny and demand for infection-prevention solutions increase, Bactiguard is well-positioned for growth. Key milestones include expanding its licensed product portfolio, entering new geographic markets, and pursuing FDA clearances for additional applications.

Upcoming Catalysts (preview)

• Q2 2027FDA clearance for coated endotracheal tube70% success
• Q4 2026New licensing agreement with major medical device manufacturer60% success
• Q3 2026Positive clinical trial results for coated urinary catheter in pediatric patients75% success